Advanced search
Publication Cover
Autoimmunity Volume 36, 2003 - Issue 1
Submit an article Journal homepage
199
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Lupus Pregnancy

Michael D. Lockshin Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA; Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
&
Lisa R. Sammaritano Joan and Sanford Weill College of Medicine of Cornell University, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
Pages 33-40 | Published online: 07 Jul 2009

  • Cunningham, F.G., Mac Donald, P.C., Gant, N.F., Leveno, K.J.,Gilstrap, L.C., Hankins, G.D.Q., et al. (1997) Williams Obstetrics,20th ed. (Appleton and Lange, Stamford), pp 533-535.
  • Burrows, R.F. and Kelton, I.G. (1988) "Incidentally detectedthrombocytopenia in healthy mothers and their infants", N. Engl. J.Med. 319, 142-145.
  • Vaziri, N.D., Toohey, J., Powers, D., Keegan, K., Gupta, A.,Alikhani, S., et al. (1986) "Activation of intrinsic coagulationpathway in pre-eclampsia", Am. J. Med. 80, 103-107.
  • Gerbasi, F.R., Bottoms, S., Farag, A. and Mammen, E. (1990)"Increased intravascular coagulation associated with pregnancy",Obstet. Oynecol 75, 385-392.
  • Toglia, M.R. and Weg, J.G. (1996) "Venous thromboembolismduring pregnancy", N. Engl. J. Med. 335, 107-114.
  • Kittner, S.J., Stern, B.J., Feeser, B.R., Hebil, J.R., Nagey, D.A.,Buchholz, D.W., et al (1996) "Pregnancy and the risk of stroke",N. Engl. J. Med. 335, 768-774.
  • Bokarewa, M.E., Bremme, K. and Blomback, M. (1996) "Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy",Br. J. Haematol. 92, 473-478.
  • Lee, R.V. (1996) "Thromboembolic disease and pregnancy: are allwomen created equal?", Ann. Intern. Med. 125, 1001-1002.
  • Martinelli, I., Taioli, E, Cetin, I., Marinoni, A., Gerosa, S., Villa,M.V., et al. (2000) "Mutations in coagulation factors in women withunexplained late fetal loss", N. Engl J. Med. 343, 1015-1018.
  • Gris, J.C., Quire, I., Monpeyroux, E, Mercier, E., Ripart-Neveau, S.,Tailland, M.L., et al (1999) "Case-control study of thefrequency of thrombophilic disorders in couples with late foetalloss and no thrombotic antecedent--the Nimes obstetricians andhaemotologists study 5 (NOHAS)", Thromb. Haemostasis 81(6),891-899.
  • Espana, E, Villa, P., Mira, Y, Grancha, S., Royo, M., Estelies, A.,Vaya, A. and Azner, J. (1999) "Factor V Leiden and antibodiesagainst phospholipid and protein S in a young woman with recurrentthromboses and abortion", Haematologica 84(1), 80-84.
  • Lockshin, M.D. (1993) "Pregnancy and systemic autoimmunedisease", Semin. Clin. Immunol. 5, 5-11.
  • Gleicher, N. (1992) "Autoantibodies in normal and abnormalpregnancy", Am. J. Reprod. Immunol. 28, 269-273.
  • El-Roeiy, A. and Gleicher, N. (1988) "Definition of normalautoantibody levels in an apparently healthy population", Obstet.Gynecol. 72, 596-602.
  • Kwak, J.Y.H., Gilman-Sachs, A., Beaman, K.D. and Beer, A.E.(1992) "Autoantibodies in women with primary recurrentspontaneous abortion of unknown etiology", J. Reprod. Immunol.22, 15-31.
  • Hill, I.A. (1992) "Cytokines considered critical in pregnancy", Am.J. Reprod. Immunol. 28, 123-126.
  • Chaouat, G., Menu, E., Clark, D.A., Dy, M., Minkowski, M.and Wegmann, T.G. (1990) "Control of fetal survival in CBA XDBA/2 mice by lymphokine therapy", J. Reprod. Fertil. 89,447-458.
  • Lahita, R.G. (1992) "The effects of sex hormones on the immunesystem in pregnancy", Am. J. Reprod. Immunol. 28, 136-137.
  • Sthoeger, Z.M., Chiorazzi, N. and Lahita, R.G. (1988) "Regulationof the immune response by sex hormones. 1. In vivo effects ofestradiol and testosterone on pokeweed mitogen induced B-celldifferentiation", J. Immunol. 141, 91-98.
  • Buyon, J.P., Tamerius, J., Ordorica, S., Young, B. and Abramson,S.B. (1992) "Activation of the alternative complement pathwayaccompanies disease flares in systemic lupus erythematosus duringpregnancy", Arthritis Rheum. 36, 55-61.
  • Levy, R.A., Qamar, T. and Lockshin, M. (1990) "Alternativecomplement pathway in hypocomplementemic/normal Cls-Clinhibitor complex patients with SLE", Clin. Exp. Rheumatol. 8,11-15.
  • Xu, C., Mao, D., Holers, V.M., Palanca, B., Cheng, A.M. andMolina, H. (2000) "A critical role for murine complement regulatorCRRY in fetomaternal tolerance", Science 287, 498-501.
  • Holers, V.M., Girardi, G., Mo, L., Guthridge, J.M., Molina, H.,Pierangeli, S.S., et al. (2002) "Complement C3 activation isrequired for anti-phospholipid antibody-induced fetal loss", J. Exp.Med. 195, 211-220.
  • Amant, F., Spitz, B., Amout, I. and Van Assche, R.A. (1997)"Hepatic necrosis and haemorrhage in pregnant patients withantiphospholipid antibodies", Lupus 6, 552-555.
  • Castle, S.P., Mather-Mondrey, M., Bennion, S., David-Bajar, K. andHuff, C. (1996) "Chronic herpes gestationis and antiphospholipidantibody syndrome successfully treated with cyclophosphamide",J. Am. Acad Dermatol. 34, 333-336.
  • Cunningham, EG., Mac Donald, P.C., Gant, N.F., Leveno, K.J.,Gilstrap, L.C., Hankins, G.D.V., et al (1997) Williams Obstetrics,20th ed. (Appleton and Lange, Stamford), pp 943-965.
  • Ward, R.M. (1993) "Drug therapy of the fetus", J. Clin. Pharmacol.33, 780-789.
  • Piper, I.M., Baum, C. and Kennedy, D.L. (1987) "Prescription druguse before and during pregnancy in a Medicaid population", Am.J. Obstet. Gynecol. 157, 148-157.
  • Eishi, Y, Hirokawa, K. and Hatakeyama, S. (1983) "Long-lastingimpairment of immune and endocrine systems of offspring inducedby injection of dexamethasone into pregnant mice", Clin. Immunol.Immunopathol. 26, 335-349.
  • Anderson, G.G., Rotchell, Y and Kaiser, D.G. (1981) "Placenta!transfer of methylprednisolone following maternal intravenousadministration", Am. J. Obstet. Gynecol. 140, 699-701.
  • Hensleigh, P.A., Herzenberg, L.A., Lipman, S.H., Malvehy, R.M.,Medearis, A.L., Moore, M.H., et al. (1983) 'Transient immunologieeffects of betamethasone in human pregnancy after suppression ofpre-term labor", Am. J. Reprod. Immunol. 4, 83-87.
  • Rayburn, W.F. (1992) "Glucocorticoid therapy for rheumaticdisease. Maternal, fetal, and breast-feeding considerations", Am.J. Reprod. Immunol. 28, 138-140.
  • Bermas, B.L. and Hill, I.A. (1995) "Effects of immunosuppressivedrugs during pregnancy", Arthritis Rheum. 38, 722-732.
  • Meehan, R.T. and Dorsey, K.T. (1987) "Pregnancy among patientswith systemic lupus erythematosus receiving immunosuppressivetherapy", J. Rheumatol 14, 252-258.
  • Dewitte, D.B., Buick, M.K., Cyran, S.E. and Maisels, M.J. (1984)"Neonatal pancytopenia and severe combined immunodeficiencyassociated with antenatal administration of azathioprine andprednisone", J. Pediatr. 105, 625-628.
  • Fein, A., Gross, A., Serr, D.M. and Nebel, L. (1983) "Effect ofImuran on placenta! and fetal development in rats", Isr. J. Med. Set.19, 73-75.
  • Langevitz, P., Klein, L., Pras, M. and Many, A. (1992) "The effect ofcyclophosphamide pulses on fertility in patients with lupusnephritis", Am. J. Reprod. Immunol. 28, 157-158.
  • Roubenoff, R., Hoyt, J., Petri, M., Hochberg, M.C. and Hellman,D.B. (1988) "Effects of Antiinflammatory and immunosuppressivedrugs on pregnancy and fertility", Semin. Arthritis Rheum. 18,88-110.
  • Buchanan, N.M., Toubi, E., Khamashta, M.A., Lima, E, Kerslake, S.and Hughes, G.R. (1996) "Hydroxychloroquine and lupuspregnancy: review of a series of 36 cases", Ann. Rheum. Dis. 55,486-488.
  • Arnout, J., Spitz, B., Wittevrongel, C., Vanrusselt, M., Van Assche, A. and Vermylen, J. (1994) "High dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome", Thromb. Haemostasis 71, 741-747.
  • Spinnatto, I.A., Clark, A.L., Pierangeli, S.S. and Harris, E.N. (1995) "Intravenous immunoglobulin therapy for the antiphospholipid syndrome", Am. J. Obstet. Gynecol. 172, 690-694.
  • Sherer, Y., Levy, Y. and Shoenfeld, Y. (2000) "Intravenous immunoglobulin therapy of antiphospholipid syndrome", Rheumatology (Oxf.) 39, 421-426.
  • Branch, D.W., Peaceman, A.M., Druzin, M., Silver, R.K., El-Sayed, Y, Silver, R.M., et ai (2000) "A multicenter placebo-controlled study of intravenous immunoglobulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group", Am. J. Obstet. Gynecol. 182, 122-127.
  • Canadian Hydroxychloroquine Study Group(1991) "A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus", N. Engl J. Med. 324, 150-154.
  • Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. and Hughes, G.R. (1995) "The management of thrombosis in the antiphospholipid-antibody syndrome", N. Engl. J. Med. 332, 993-997.
  • Liang, M.H., Socher, S.A., Roberts, W.N. and Esdaile, J.M. (1988) "Measurement of systemic lupus erythematosus activity in clinical research", Arthritis Rheum. 31, 817-825.
  • Buyon, I.P., Kalunian, K.C., Ramsey-Goldman, R., Petri, M., Lockshin, M. and Khamashta, M. (1999) "Assessing disease activity in SLE patients during pregnancy", Lupus 8, 677-684.
  • Petri, M., Howard, D. and Repke, I. (1991) "Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience". Arthritis Rheum. 34, 1538-1545.
  • Lockshin, M.D., Reinitz, E., Druzin, M.L., Murrman, M. and Estes, D. (1984) "Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy", Am. J. Med. 77, 893-898.
  • Ruiz-Irastorza, G., Lima, F, Alves, I., Khamashta, M.A., Simpson, J., Hughes, G.R., et al. (1996) "Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies", Br. J. Rheumatol. 35, 133-138.
  • Urowitz, M.B., Gladman, D.D., Farewell, V.T., Stewart, J. and McDonald, J. (1993) "Lupus and pregnancy studies", Arthritis Rheum. 36, 1392-1397.
  • Lockshin, M.D. (1992) 'Treatment of lupus pregnancy: can we reach consensus? (editorial)", Clin. Exp. Rheumatol. 10, 429-431.
  • Ruiz-Irastorza, G., Khamashta, M.A., Gordon, C., Lockshin, M.D., Johns, K.R., Sammaritano, L., et al. (2002) "Measuring systemic lupus erythematosus activity during pregnancy: validation of LAI-P and SLEPDAI scales", Arthritis Care Res., In press.
  • Packham, D.K., Lam, S.S., Nicholls, K., Fairley, K.F. and Kincaid-Smith, P.S. (1992) "Lupus nephritis and pregnancy", Q. J. Med 83, 315-324.
  • Druzin, M.L. (1988) "Pregnancy induced hypertension and preeclampsia: the fetus and the neonate", In: Rubin, P.C., ed, Handbook of Hypertension, Vol 10: Hypertension in Pregnancy (Elsevier, Amsterdam), pp. 267-289.
  • Lockshin, M.D., Qamar, T., Redecha, P. and Harpel, P.C. (1986) "Hypocomplementemia with low Cls-Cl inhibitor complex in systemic lupus erythematosus", Arthritis Rheum. 29, 1467-1472.
  • Buyon, J.P., Cronstein, B.N., Morris, M., Tanner, M. and Weissmann, G. (1986) "Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia", Am J. Med. 81, 194-200.
  • Nossent, H.C. and Swaak, T.I.G. (1990) "Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy", J. Rheumatol. 17, 771-776.
  • Beaufils, M., Donsimoni, R., Uzan, S., Donsimoni, R. and Colau, J.C. (1985) "Prevention of pre-eclampsia by early antiplatelet therapy", Lancet 1, 840-842.
  • Wallenburg, H.C.S., Dekker, G.A., Makovitz, J.W. and Rotmans, P. (1986) "Low dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae", Lancet 1, 1-3.
  • Dekker, G.A. and Sibai, B.M. (1993) "Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials", Am J. Obstet. Gynecol. 168, 214-227.
  • Schiff, E. and Mashiach, S. (1992) "The use of low-dose aspirin in pregnancy", Am. J. Reprod. Immunol. 28, 153-156.
  • Besa, E.C., MacNab, M.W., Solan, A.J., Lapes, M.J. and Marfatia, U. (1985) "High-dose intravenous IgG in the management of pregnancy in women with idiopathic thrombocytopenic purpura", Am. J. Hematol. 18, 373-379.
  • Fehr, I., Hofmann, V. and Kappeier, U. (1982) 'Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by highdose intravenous gamma globulin", N. Engl. J. Med. 306, 1254-1258.
  • Newland, A.C., Boots, M.A. and Patterson, K.G. (1984) "Intravenous IgG for autoimmune thrombocytopenia in pregnancy", N. Engl J. Med. 310, 261-262.
  • Salafia, C.M. and Cowchock, F.S. (1997) "Placental pathology of antiphospholipid antibodies--a descriptive study", Am. J. Perinatal. 14,435-441.
  • Magid, M.S., Kaplan, C., Sammaritano, L.R., Peterson, M., Druzin, M.L. and Lockshin, M.D. (1998) "Placental pathology in systemic lupus erythematosus: a prospective study", Am. J. Obstet. Gynecol. 179, 226-234.
  • Out, H.J., Kooijman, C.D., Bruinse, H.W. and Derksen, R.H. (1991) "Histopathologic findings in placentae from patients with intrauterine fetal death and anti-phospholipid antibodies", Ear. J. Obstet. Gynecol. Repmd. Biol. 41, 179-186.
  • Faulk, W.P. and Labarrere, C.A. (1992) "Vascular events in placentae and organ allografts", Am. J. Reprod. Immunol. 28, 176-180.
  • McIntyre, J.A. (1992) "Immune recognition at the maternal fetal interface. Overview", Am. J. Reprod. Immunol. 28, 127-131.
  • Sammaritano, L.R., Gharavi, A.E., Soberano, C., Levy, R.A. and Lockshin, M.D. (1992) "Phospholipid binding of antiphospholipid antibodies and placenta! anticoagulant protein", J. Clin. Immunol. 12, 27-35.
  • Rand, J.H., Wu, X.X., Andree, H.A.M., Lockwood, C.J., Culler, S., Scher, J., et al (1997) "Pregnancy loss in the antiphospholipidantibody syndrome--a possible thrombogenic mechanism", N. Engl J. Med. 337, 154-160.
  • La Rosa, L., Meroni, P.L., Tincani, A., Balestrieri, G., Faden, D., Lojacono, A., et al. (1994) "Beta-2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid antibody syndrome", J. Rheumatol. 21, 1684-1693.
  • Grennan, D.M., McCormick, I.N., Wojtacha, D., Carry, M. and Behan, W. (1978) "Immunological studies of the placenta in systemic lupus erythematosus", Ann. Rheum. Dis. 37, 129-134.
  • Petri, M., Ho, A.C., Patel, J., Demers, D., Joseph, J.M. and Goldman, D. (1995) "Elevation of maternal alpha-fetoprotein in systemic lupus erythematosus: a controlled study", J. Rheumatol. 22, 1365-1368.
  • Yetman, D.L., Kutteh, W.H., Castorena, R., Brown, C. and Baskin, L. (1997) "Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alfa-fetoprotein", J. Reprod. Immunol. 33, 71-81.
  • Clark, E, Dickinson, I.E., Walters, B.N.J., Marshall, L.R. and O'Leary, P.C. (1995) "Elevated midtrimester hCG and maternal lupus anticoagulant", Prenatal Diagn. 15, 1035-1040.
  • Sammaritano, L.R., Ng, S., Sobel, R., Lo, S.K., Simantov, R., Furie, R., et al. (1997) "Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis", Arthritis Rheum. 40, 1998-2006.
  • Navarro, E, Dona-Naranjo, M.A. and Villanueva, I. (1997) "Neonatal antiphospholipid syndrome", J. Rheum. 24, 1240-1241.
  • Pollard, J.K., Scott, J.R. and Branch, D.W. (1992) "Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome", Obstet. Gynecol. 80, 365-368.
  • McAllister, D.L., Kaplan, B.J., Edworthy, S.M., Martin, L., Crawford, S.G., Ramsey-Goldman, R., et al. (1997) "The influence of systemic lupus erythematosus on fetal development: cognitive, behavior and health trends", J. Int. Neuropsychol. Soc. 3, 370-376.
  • Ross, G., Sammaritano, S., Nass, R. and Lockshin, M. (2002) "Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children", Arch. Pediatr. Adolesc. Med., In press.
  • Cunningham, E.G., Mac Donald, P.C., Gant, N.F., Leveno, K.J., Gilstrap, L.C., Hankins, G.D.V., et al (1997) Williams Obstetrics, 20th ed. (Appleton and Lange, Stamford), pp. 535-540.
  • Yuen, B.H. (1988) "Prolactin in human milk: the influence of nursing and the duration of postpartum lactation", Am. J. Obstet. Gynecol. 158, 583-588.
  • Gardner, D.K. (1992) "Drugs in breast milk", In: Rayburn, W.F. and Zuspan, F.P., eds, Drug Therapy in Obstetrics and Gynecology (Mosby Yearbook Company, St. Louis), pp. 312-325.
  • Townsend, R.I., Benedetti, T.J., Erikson, S.H., Cengiz, C., Gillespie, W.R., Gschwend, J., et al. (1984) "Excretion of ibuprofen into breast milk", Am. J. Obstet. Gynecol. 149, 184-188.
  • Guballa, N., Sammaritano, L., Schwartzman, S., Buyon, I. and Lockshin, M. (2000) "Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome", Arthritis. Rheum. 43, 550-556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.